KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aurinia Pharmaceuticals (AUPH) Total Current Liabilities (2018 - 2025)

Historic Total Current Liabilities for Aurinia Pharmaceuticals (AUPH) over the last 10 years, with Q3 2025 value amounting to $76.2 million.

  • Aurinia Pharmaceuticals' Total Current Liabilities fell 303.91% to $76.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $76.2 million, marking a year-over-year decrease of 303.91%. This contributed to the annual value of $97.8 million for FY2024, which is 2665.57% up from last year.
  • Latest data reveals that Aurinia Pharmaceuticals reported Total Current Liabilities of $76.2 million as of Q3 2025, which was down 303.91% from $78.3 million recorded in Q2 2025.
  • In the past 5 years, Aurinia Pharmaceuticals' Total Current Liabilities registered a high of $97.8 million during Q4 2024, and its lowest value of $21.2 million during Q1 2021.
  • Its 5-year average for Total Current Liabilities is $57.2 million, with a median of $61.7 million in 2023.
  • In the last 5 years, Aurinia Pharmaceuticals' Total Current Liabilities surged by 7807.72% in 2023 and then plummeted by 372.4% in 2025.
  • Over the past 5 years, Aurinia Pharmaceuticals' Total Current Liabilities (Quarter) stood at $40.6 million in 2021, then increased by 13.44% to $46.1 million in 2022, then skyrocketed by 67.41% to $77.2 million in 2023, then grew by 26.66% to $97.8 million in 2024, then dropped by 22.04% to $76.2 million in 2025.
  • Its Total Current Liabilities stands at $76.2 million for Q3 2025, versus $78.3 million for Q2 2025 and $68.4 million for Q1 2025.